10/8/2019MSD's KEYTRUDA Approved in First-Line Setting for NSCLC in China

10/3/2019CBMG Builds R&D Center in MD as Its ReJoin Stem Cell Therapy Accep...

10/3/2019NMPA Approves IND for Fully-human BCMA CAR-T

10/3/2019Hrain Biotech Completes $28M Series B Round Fund Raising

10/3/2019NMPA Solicits Comments on the Provisions for Control of Drug Distribut...

10/2/2019NMPA Solicits Comments on the Provisions for Control of Drug Manufactu...

10/2/2019NMPA Solicits Comments on the Provisions on Registration of Drug Produ...

10/1/2019FiercePharma: Big Pharma CEOs' Chinese Names

10/1/2019Central Government Issues Implementation Opinions for Expanding 4+7 Tr...

9/30/2019Pharma Industry Face Unprecedented Price Pressure in Expanded 4+7 Tend...

9/30/2019Financial-related Company News in Brief

9/30/2019Eisai and Nichi-Iko Enter Partnership for Generic Drugs in China

9/30/2019Central Government Issues New Policy for Healthcare Sector Development...

9/30/2019Chinese Health Authorities Pledge to Prioritize Rural Development

9/30/2019CFC Launches Chinese Lung Cancer Knowledge Platform

9/30/2019Erbitux 1L with FOLFOX or FOLFIRI Approved in China for RAS Wild-type ...

9/30/2019CDE Seeks Comments on Implementation Suggestions for ICH Q Series Guid...

9/30/2019CDE Seeks Comments on Draft Chinese Translations of ICH E2A Guideline

9/29/2019Kalbe Genexine Biologics Enters Exclusive Licensing of Henlius's I/O P...

9/27/2019NHSA Sets Timeline for Phasing Out Provincial Level Additions of NRDL

9/27/2019Recent Executive Moves

9/27/2019AstraZeneca’s Lung Cancer Drug Receives Regulatory Approval In China

9/27/2019NMPA Confirms Withdrawal of GMP and GSP Certifications, Pledging Timel...

9/26/2019As Tariffs Affect the Pharma Industry, Business Strategies Must Evolve

9/26/2019India and China Spark Concerns for UK Drug Supplies

9/26/2019Thermo Fisher Scientific Expands Clinical Trials Capabilities and Anno...

9/26/2019Sanofi, AZ, Lilly and More Win Business in China's Expanded Cut-price ...

9/26/2019NHSA: BMI Reimbursed Nearly CNY 2B for 17 Anticancers in H1

9/25/2019CDE Solicits Comments over Two Guidelines on Clinical Data Monitoring ...

9/25/2019NMPA Officially Joins IMDRF NCAR Exchange Program

Page:280/789 Total number of articles:23668: [First][<<] [278] [279] [280] [281] [282] [>>] [End]